Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/19/26 17:00 | 2/17/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | Jallal Bahija | X0 | DO | CEO | 2 | M.d | 371 | 10.52 | 0 | 35 | 12 | D | |||||||||||||||
2/19/26 17:00 | 2/18/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | Jallal Bahija | X0 | DO | CEO | 2 | S.d | -371 | 10.52 | 0 | -35 | 12 | D | |||||||||||||||
2/19/26 17:00 | 2/17/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | Goll John | X0 | O | SVP,FINA | 2 | M.d | 23 | 11.02 | 0 | 2 | 1 | D | |||||||||||||||
2/19/26 17:00 | 2/18/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | Goll John | X0 | O | SVP,FINA | 2 | S.d | -23 | 11.02 | 0 | -2 | 1 | D | |||||||||||||||
2/19/26 17:00 | 2/17/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | St Leger Tina Amber | X0 | O | CHRO | 2 | M.d | 32 | 10.37 | 0 | 3 | 1 | D | |||||||||||||||
2/19/26 17:00 | 2/18/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | St Leger Tina Amber | X0 | O | CHRO | 2 | S.d | -32 | 10.37 | 0 | -3 | 1 | D | |||||||||||||||
2/19/26 17:00 | 2/17/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | Berman David M | X0 | O | HEAD OF | 2 | M.d | 193 | 10.85 | 0 | 18 | 6 | D | |||||||||||||||
2/19/26 17:00 | 2/18/26 | IMCR | Health | BioPrd | Biological Products, (No Diag | Berman David M | X0 | O | HEAD OF | 2 | S.d | -193 | 10.85 | 0 | -18 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |